Clinical Trials Search
Clinical Trial 20372
Cancer Type: Malignant Hematology
Study Type: Other
NCT#: NCT04319237
Phase: N/A
Prinicipal Investigator: Heather Jim
Study Title
Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes
Summary
The purpose of the study is to assess self-reported side effects and neurocognitive (brain, mood and thinking) functioning among patients treated with commercial axi-cel therapy.
Objective
Aim 1: To evaluate longitudinal changes in neurocognition following axi-cel therapy Aim 2: Describe longitudinal changes in patient-reported outcomes for patients receiving axi-cel cell therapy.
Therapies
Medications
Inclusion Criteria:
If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.